Analyst Ratings for Damora Therapeutics (DMRA)
DMRA Rating Summary
DMRA Price Target Summary
- Highest: $60.00 (Guggenheim)
- Lowest: $35.00 (Wedbush)
- Average: $47.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$47.29 (+156.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/22/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
30.31 (18.44) |
-39.16% | Details |
| 7/27/2026 | Jefferies | Akash Tewari | New Coverage | Buy (N/A) |
50.00 (N/A) |
29.17 (18.44) |
-36.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
